AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06418321 — intervention group
Intervention type: OTHER
Intervention: Audiometer
Description: Participants' hearing thresholds are tested with an audiogram.
Study NCT06418321 — intervention group
Intervention type: DEVICE
Intervention: Otomicroscopy
Description: The status of the participants' ear canals and tympanic membranes are checked.
Study NCT06418321 — intervention group
Intervention type: OTHER
Intervention: REM (Real Ear Measurements)
Description: The acoustic properties of the participants' ears will be measured during the interventions.
Study NCT05369299 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implant Straumann® Pure Ceramic Two Piece Implant
Description: Dental implants are placed directly after tooth extraction in the extraction socket.
Study NCT05369299 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: two-piece titanium implant Neoss® ProActive Tapered Implant
Description: Dental implants are placed directly after tooth extraction in the extraction socket.
Study NCT06017999 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XG005 tablet
Description: Subjects will receive XG005 prior to surgery and every 12 hours for 72 hours.
Study NCT06017999 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo tablet
Description: Subjects will receive placebo prior to surgery and every 12 hours for 72 hours.
Study NCT06017999 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablet
Description: Subjects will receive placebo prior to surgery and every 12 hours for 72 hours.
Study NCT05636553 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage
Description: Individualised treatment using massage techniques such as longitudinal gliding, transverse gliding, digital ischemic pressure, transverse frictions, and transverse gliding.
Study NCT05864651 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tele-exercise program
Description: The tele-exercise program focused on lunge movement with additional strengthening abdominal and lumbopelvic muscle training while maintaining neuromuscular control. The difficulty of training was adjusted every week according to the five-step mastery program
Study NCT05864651 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Fencing Exercise
Description: The conventional exercise was based on 'displacement', a basic footwork training in fencing. The Displacement is also basic footwork to approach the opponent. The Displacement consisted of seven movements including 'Marche', 'Retraite \& Rompre', 'Passe avant', 'Passe arrière', 'Bond en avant', 'Bond en arrière', and 'Balestra'.
Study NCT05864651 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Fencing Exercise
Description: The conventional exercise was based on 'displacement', a basic footwork training in fencing. The Displacement is also basic footwork to approach the opponent. The Displacement consisted of seven movements including 'Marche', 'Retraite \& Rompre', 'Passe avant', 'Passe arrière', 'Bond en avant', 'Bond en arrière', and 'Balestra'.
Study NCT05261633 — intervention group
Intervention type: DEVICE
Intervention: Diffusion Weighted Magnetic Resonance Imaging
Description: Diffusion-weighted (DW)-MRI has a unique ability to probe tissue microstructure without the need for ionizing radiation or intravenous contrast agents. DW-MRI of the abdomen is utilized in detection, staging, and treatment surveillance of malignancies, and has shown great promise in various other applications, including for the assessment of fibrosis in the liver, pancreas, kidneys, and other organs.
Study NCT06105190 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implantation of premium monofocal IOL, LuxSmart (device under investigation)
Description: Patients will be implanted with study IOL in both eyes
Study NCT06105190 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantation of monofocal IOL, LuxGood (control device)
Description: Patients will be implanted with Control IOL in both eyes
Study NCT06553079 — intervention group
Intervention type: OTHER
Intervention: Surgeon Satisfaction Self-Assessment Questionnaire for Shoulder Arthroscopy
Description: The intervention in this study involves the administration of the Surgeon Satisfaction Self-Assessment Questionnaire for Shoulder Arthroscopy, a newly developed tool designed to measure various aspects of surgeon satisfaction related to shoulder arthroscopy procedures.
Study NCT05872932 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: gastric balloon implantation
Description: After diagnostic endoscopy if there is no any gastric pathology that would be contraindication for balloon placement a gastric balloon will be placed
Study NCT05872932 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: botulinum toxin A injection
Description: After diagnostic endoscopy if there is no any gastric pathology that would be contraindication Botox injection and balloon placement, 200 U of Botox A will be injected to antrum and fundus. And 1 week later gastric balloon will be implanted
Study NCT04843540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CTP-543
Description: Rifampin as oral capsule
Study NCT06376617 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: fibroptic bronchoscopy
Description: take bal through fibrooptic bronchoscopy and send for stain and culcure
Study NCT04993703 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: A total of 20 sessions physiotherapy sessions including hot pack, ultrasound, kinesiotaping and exercise program (tendon and nerve gliding exercises=2 times per day 3 sets of ten repetitions) will be applied.times per day 3sets of ten repetitions) will be applied.
Study NCT04993703 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Night Splinting
Description: A total of 20 sessions physiotherapy sessions including hot pack, ultrasound, night splinting and exercise program (tendon and nerve gliding exercises=2 times per day 3 sets of ten repetitions) will be applied.
Study NCT04993703 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: A total of 20 sessions physiotherapy sessions including hot pack, ultrasound and exercise program (tendon and nerve gliding exercises=2 times per day 3 sets of ten repetitions) will be applied.
Study NCT06612502 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Static stretching
Description: The static stretching protocol comprised eight exercises, performed for 30 seconds per bilateral muscle group (with the exception of the sitting toe touch and butterfly stretch), and included the hip, knee, and ankle. The subjects were instructed to perform the following sequence of stretches: forward lunge, supine knee flexion, lateral quadriceps stretch, sitting toe touch, semi-straddle, straddle, butterfly stretch, and a straight knee ankle extensor wall stretch. Each subject completed each stretch before progressing to the subsequent one. The stretches were maintained until the subject experienced mild discomfort, but not pain.
Study NCT06783192 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-8527
Description: MK-8527 capsule taken by mouth
Study NCT06783192 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNG/EE
Description: LNG/EE combination tablet taken by mouth.
Study NCT06785922 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Stomach biopsy for gastric microbiota
Description: Stomach biopsy for gastric microbiota testing (16S RNA sequencing)
Study NCT06783439 — intervention group
Intervention type: OTHER
Intervention: Ultrasound
Description: The ultrasound probe will be placed parallel to the body of the piriformis muscle on an imaginary line drawn from the sacrum to the greater trochanter of the femur. This area is also the sensitive area of the patients during the examination with pressure, and when the US probe is in this position, the subcutaneous fat tissue, gluteus maximus muscle, piriformis muscle, and the upper and lower borders of the sciatic nerve will be displayed in order from superficial to deep. First, the maximum thickness of the piriformis muscle body will be measured, then the thickness of the sciatic nerve will be measured, and the same measurements will be applied to the patient's asymptomatic hip, and the measurements will be recorded.
Study NCT06786806 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gamified Infection Control Education Program
Description: A four-week educational program integrating gamification techniques such as physical games, case studies, and escape rooms to teach infection control practices.Designed to enhance engagement, learning motivation, and cognitive achievement among nursing students.
Study NCT06786806 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Traditional Lecture-Based Instruction
Description: Standard didactic teaching method focusing on infection control principles without incorporating gamification. Served as the comparator to evaluate the effectiveness of the gamified program.
Study NCT06787911 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafeib with Sintilimab
Description: Patients receive Donafenib and PD-1 antibody Sintilimab
Study NCT06784258 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: General Anesthesia (control group)
Description: The patient will undergo conventional general anesthesia with a regimen of intravenous fentanyl 1-2 mcg/kg BW, propofol 2-3 ml/kg BW, and muscle relaxants for intubation, such as atracurium 0.5 mg/kg BW or rocuronium 0.6 mg/kg BB. After that the patient will be intubated
Study NCT06784258 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: General Anesthesia combined with epidural anesthesia
Description: The patient will undergo epidural anesthesia first with an epidural catheter inserted through a Tuohy needle and ensuring that the length of the multihole epidural catheter that enters the epidural space is 5-6 cm. After that, the patient underwent conventional general anesthesia with a regimen of intravenous fentanyl 1-2 mcg/kg BW, propofol 2-3 ml/kg BW, and muscle relaxants for intubation, such as atracurium 0.5 mg/kg BW or rocuronium 0.6 mg/ kg BW. After that the patient will be intubated. The patient will be given local anesthesia Bupivacaine 0.25% in increments to the desired volume according to the desired height of the segmental block. Local anesthetic medication will be given intermittently every 2 hours
Study NCT06783023 — intervention group
Intervention type: OTHER
Intervention: validity and reliability study
Description: In the study, which will include at least 24 individuals with CIED determined by power analysis, unassisted arm exercise capacity and arm function/endurance, maximum arm exercise capacity, double product, heart recovery, comorbidity level, hand grip strength, fear of movement, activities of daily living and quality of life will be evaluated.
Study NCT06787950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASN-3186
Description: ASN-3186 will be administered orally.
Study NCT06783569 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JR8603
Description: IV infusion on Days 1, 8, and 15 of continuous 28-day cycles
Study NCT06782594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mosapride Citrate Injection(high)
Description: Mosapride Citrate Injection, iv, 8mg, bid, for 3 to 5 days
Study NCT06782594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mosapride Citrate Injection(low)
Description: Mosapride Citrate Injection, iv, 4mg, bid, for 3 to 5 days
Study NCT06782594 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, iv, bid, for 3 to 5 days
Study NCT06785194 — intervention group
Intervention type: DEVICE
Intervention: REVIVE samfilcon B custom toric contact lenses
Description: REVIVE samfilcon B custom toric contact lenses
Study NCT06785766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga-Based Exercise Program
Description: This intervention is an 8-week yoga-based exercise program conducted with 60-minute sessions twice a week. The program aims to improve flexibility, mobility, and overall well-being. Each session consists of 5 minutes of warm-up, 5 minutes of breathing exercises, 40 minutes of yoga postures, 5 minutes of deep relaxation, and 5 minutes of meditation. The intervention adapts yoga postures based on participants' individual needs, offering a flexible approach. The difficulty of the yoga flows gradually increases over the 8 weeks. When necessary, postures are adapted using props like blocks, straps, blankets, and chairs. A physiotherapist guides participants, demonstrating correct techniques and providing verbal instructions. This program combines yoga, breathing exercises, and meditation to enhance physical and mental well-being, promoting long-term health benefits.
Study NCT06784557 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin 40mg
Description: High intensity HMG-CoA reductase inhibitor
Study NCT06784557 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20mg+Ezetimibe 10mg
Description: Moderate intensity HMG-CoA reductase inhibitor plus NPC1L1 antagonist
Study NCT06612502 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fascia gun ( Short-time PMT )
Description: The PMT was performed by the two physiotherapists using an OUTSO 06® Fascia Gun equipped with a 5 cm diameter soft attachment head and the vibration frequency was 53 Hz. The targeted muscles included the quadriceps, adductors, hamstrings, iliotibial band, and gluteal muscles for both sides. Throughout the PMT, the physiotherapists carefully maintained a consistent level of moderate pressure on the skin, and followed the direction of the muscle fibers. The short time PMT was applied for 2.5 minutes per muscle site for a total of 25 minutes.
Study NCT06612502 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fascia gun ( Long-time PMT )
Description: The PMT was performed by the two physiotherapists using an OUTSO 06® Fascia Gun equipped with a 5 cm diameter soft attachment head and the vibration frequency was 53 Hz. The targeted muscles included the quadriceps, adductors, hamstrings, iliotibial band, and gluteal muscles for both sides. Throughout the PMT, the physiotherapists carefully maintained a consistent level of moderate pressure on the skin, and followed the direction of the muscle fibers. The long time PMT was applied for 4 minutes per muscle site for a total of 40 minutes.
Study NCT04817267 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: reSET-O app
Description: The reSET-O app, a prescription digital therapeutic, provides cognitive behavioral therapy for opioid use disorder. The app provides psychoeducation related to opioid use, coping skills, and skills to avoid relapse.
Study NCT06612190 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TMS
Description: TMS treatment in this study indicates a non-invasive procedure called transcranial magnetic simulation (TMS) on visual cortex. The treatment intensity is set as 80% of the threshold of each participant. The treatment will be conducted every day for consecutive 5 days.
Study NCT06612190 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Control
Description: The sham group will be given no real magnetic stimulation.
Study NCT06269146 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pramipexole Pill
Description: The study drug, pramipexole, is an FDA-approved medication for the treatment of Parkinson's and restless leg syndrome. Pramipexole (Mirapex) tablets are taken orally, with or without food.
Study NCT06269146 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Pill
Description: Placebo will match the study drug in mode of administration, color, size, and taste.
Study NCT04788849 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: BD Onclarity™ HPV assay
Description: Women will be asked to self-collect first-void urine using Copan's UriSponge™ 8E031S100 and vaginal swabs using Copan's FLOQSwabs® 5E089N. All samples will be tested with BD Onclarity™ HPV assay. HPV test results on self-collected samples will be compared to those obtained when testing clinician-collected cervical sample
Study NCT06478082 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home-based virtual reality training
Description: 8-week training with an advised frequency of 30 minutes per day, for 5 days per week.
Study NCT06337734 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AI-Driven Lifestyle Coaching Program
Description: The intervention provides participants with automated and personalized lifestyle recommendations involving a sophisticated analytics engine using advanced statistics and machine learning.
Study NCT06443515 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: lung ultrasound
Description: Lung ultrasound examinations will be performed within 6 hours before and after blood transfusion to assess interstitial-alveolar fluid retention and calculate a LUS score
Study NCT04730752 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Appendicitis Inflammatory Response
Description: A scoring system used to diagnose acute appendicitis. It consists of clinical findings and laboratory parameters
Study NCT04730752 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Adult Appendicitis Score
Description: A scoring system used to diagnose acute appendicitis. It consists of clinical findings and laboratory parameters
Study NCT06341062 — intervention group
Intervention type: OTHER
Intervention: Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound
Description: Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound before hospital discharge
Study NCT05496465 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ARS-1
Description: A single treatment of ARS-1.
Study NCT05496465 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A single treatment of placebo nasal spray
Study NCT05195099 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: respiratory treatment
Description: Respiratory treatment based on aerobic exercise and treatment of the musculature to reduce dyspnoea and increase the capacity for exertion, neurorehabilitative treatment focusing on the sense of smell and taste to on the sense of smell and taste to increase sensitivity in post Covid-19 subjects.
Study NCT05195099 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: respiratory treatment
Description: Respiratory treatment based on aerobic exercise and treatment of the musculature to reduce dyspnoea and increase the capacity for exertion, neurorehabilitative treatment focusing on the sense of smell and taste to on the sense of smell and taste to increase sensitivity in post Covid-19 subjects.
Study NCT05511259 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Square stepping exercise
Study NCT06174194 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Tulsi Gum
Description: The intervention involves participants chewing a specially formulated gum known as Tulsi Gum for 5 minutes. Tulsi Gum contains Tulsi extract, a natural substance derived from the Tulsi plant. This extract is recognized for its potential antimicrobial properties. Participants are then required to discard the gum. The study aims to assess the effect of Tulsi Gum on salivary Streptococcus mutans count in children aged 4 to 11 years. This assessment contributes to understanding the potential of Tulsi Gum in preventing dental caries in children.
Study NCT05273229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Gait
Description: Virtual Gait: the patient will be placed in a standing position (with an ad-hoc designed help system) in front of a mirror (from the waist up) and a screen (from the waist down) where a video of legs walking on a treadmill will be projected and overcoming obstacles. Projected legs will be customized based on height, using the tibia length method.
Study NCT05273229 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Physical exercise
Description: PE: it will be divided into two parts: in the first one, a gait technique training will be carried out and, in the second, a leg strength training, for 30 min. Exercises:~* Coordination exercises: normal and lateral parallel walking and walking with obstacles.~* Functional exercises such as climbing stairs, etc.~* Lower limb strength exercises. Strength exercises will be prescribed according to the guidelines of the American College of Sports Medicine (ACSM). Progression will be customized based on individual abilities.
Study NCT05273229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical exercise
Description: PE: it will be divided into two parts: in the first one, a gait technique training will be carried out and, in the second, a leg strength training, for 30 min. Exercises:~* Coordination exercises: normal and lateral parallel walking and walking with obstacles.~* Functional exercises such as climbing stairs, etc.~* Lower limb strength exercises. Strength exercises will be prescribed according to the guidelines of the American College of Sports Medicine (ACSM). Progression will be customized based on individual abilities.
Study NCT05273229 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Virtual Gait
Description: only the placebo virtual gait.
Study NCT05271097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MyLink2Care app full functionality
Description: Participants will be shown how to download the app and use the assessment tool.
Study NCT05271097 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: MyLink2Care app major intervention features inactivated
Description: Participants will be shown how to download the app and use the assessment tool.
Study NCT05247242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lakeshore Online Fitness (Online)
Description: Online physical activity program delivered to residents of Tarrant, AL via teleconferencing technology to a local community center. Instructors from Lakeshore will lead the physical activity program. This intervention will last six weeks.